The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors.

[1]  W. Koch,et al.  GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy , 2019, Expert opinion on therapeutic targets.

[2]  Hermann Schindelin,et al.  Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome , 2017, Proceedings of the National Academy of Sciences.

[3]  P. Griffin,et al.  Molecular assembly of rhodopsin with G protein-coupled receptor kinases , 2017, Cell Research.

[4]  J. Schmitt,et al.  Raf kinase inhibitor protein: lessons of a better way for β‐adrenergic receptor activation in the heart , 2017, The Journal of physiology.

[5]  Michael George,et al.  Safety pharmacology studies using EFP and impedance. , 2016, Journal of pharmacological and toxicological methods.

[6]  W. Koch,et al.  A peptide of the RGS domain of GRK2 binds and inhibits Gαq to suppress pathological cardiac hypertrophy and dysfunction , 2016, Science Signaling.

[7]  J. Schmitt,et al.  Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy , 2015, Nature Medicine.

[8]  M. Bouvier,et al.  Mapping the Putative G Protein-coupled Receptor (GPCR) Docking Site on GPCR Kinase 2 , 2014, The Journal of Biological Chemistry.

[9]  K. Lorenz,et al.  Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy , 2013, Proceedings of the National Academy of Sciences.

[10]  K. Lorenz,et al.  Raf Kinase Inhibitor Protein (RKIP) Dimer Formation Controls Its Target Switch from Raf1 to G Protein-coupled Receptor Kinase (GRK) 2* , 2012, The Journal of Biological Chemistry.

[11]  K. Palczewski,et al.  Activation of G protein-coupled receptor kinase 1 involves interactions between its N-terminal region and its kinase domain. , 2011, Biochemistry.

[12]  J. Tesmer,et al.  Recognition in the Face of Diversity: Interactions of Heterotrimeric G proteins and G Protein-coupled Receptor (GPCR) Kinases with Activated GPCRs* , 2011, The Journal of Biological Chemistry.

[13]  Cristina Murga,et al.  The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets , 2010, British journal of pharmacology.

[14]  J. Benovic,et al.  Role of the amino terminus of G protein-coupled receptor kinase 2 in receptor phosphorylation. , 2009, Biochemistry.

[15]  J. Tesmer,et al.  A Surface of the Kinase Domain Critical for the Allosteric Activation of G Protein-coupled Receptor Kinases* , 2009, The Journal of Biological Chemistry.

[16]  W. Koch,et al.  Substrate Specificities of G Protein-Coupled Receptor Kinase-2 and -3 at Cardiac Myocyte Receptors Provide Basis for Distinct Roles in Regulation of Myocardial Function , 2007, Molecular Pharmacology.

[17]  N. Dzimiri,et al.  Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. , 2004, European journal of pharmacology.

[18]  K. Lorenz,et al.  Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2 , 2003, Nature.

[19]  J. Benovic,et al.  Development of a Yeast Bioassay to Characterize G Protein-coupled Receptor Kinases , 2003, Journal of Biological Chemistry.

[20]  J. Benovic,et al.  G Protein-coupled Receptor Kinase 2/Gαq/11Interaction: A NOVEL SURFACE ON A REGULATOR OF G PROTEIN SIGNALING HOMOLOGY DOMAIN FOR BINDING Gα SUBUNITS , 2003 .

[21]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[22]  M. Sallese,et al.  Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq. , 2000, Molecular pharmacology.

[23]  Lin Li,et al.  The Amino Terminus with a Conserved Glutamic Acid of G Protein‐Coupled Receptor Kinases Is Indispensable for Their Ability to Phosphorylate Photoactivated Rhodopsin , 1999, Journal of neurochemistry.

[24]  J B Hurley,et al.  Ca-dependent Interaction of Recoverin with Rhodopsin Kinase (*) , 1995, The Journal of Biological Chemistry.

[25]  J. Benovic,et al.  G protein-coupled receptor kinases: Past, present and future. , 2018, Cellular signalling.

[26]  J. Schmitt,et al.  A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy , 2009, Nature Medicine.

[27]  Antonio S. Tutor,et al.  Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. , 2006, Cardiovascular research.